Scribe Therapeutics
SCTX22.4507.75% ( +1.615 )
Scribe Therapeutics (SCTX)
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to ad...
- Open
- 21.110
- High
- 22.630
- Low
- 20.500
- Prev. Close
- 20.835
- Volume
- 91.68K
- Turnover
- 1.98M
- Avg Price
- 21.577
- Bid/Ask Ratio
- --
- Amplitude
- 10.22%
- 52wk High
- 25.490
- Volume Ratio
- 0.16
- Turnover Ratio
- 1.06%
News
- Price Alert · Jul 31 at 05:23 AM
Popular pre-market trades in US stocks: Rectitude up 17.30% in pre-market; Scribe Therapeutics up 14.12% in pre-market
- TradingView · Jul 30 at 08:36 PM
Behzad Aghazadeh Holds Board Seat at Scribe Therapeutics with 16.37% Stake
- benzinga_article · Jul 30 at 04:05 PM
12 Health Care Stocks Moving In Thursday's After-Market Session
- Price Alert · Jul 30 at 12:08 PM
U.S. stock market midday update: Scribe Therapeutics up 20.75%, OrbiMed increases holdings by 1 million shares boosting confidence
- Price Alert · Jul 30 at 07:29 AM
Pre-market hot trades in US stocks: Scribe Therapeutics up 7.95% in pre-market; Marvell Tech up 4.88% in pre-market
- TradingView · Jul 29 at 05:46 PM
OrbiMed Advisors Discloses Investment in Scribe Therapeutics with 7.2% Stake
